Ron Connolly

Current

• Sr. Vice President at Frontage Laboratories, Inc.

Past

• Technical Affairs Manager at Flavine North America
• Sr. Research Scientist at Wyeth Pharmaceuticals, esiLederle
• Sr. Research Scientist at Wyeth

• Scientist at Rhone Poulenc Rorer (Aventis)

see less...

1 more...

Education

• Drexel University

Connections

29 connections

Industry

Pharmaceuticals

Websites

• My Company
• The River of Cherry Hill, NJ

Ron Connolly’s Summary

Frontage is a full service drug development company located in Pennsylvania, New Jersey and Shanghai, China. We have been selected as one of the fastest growing companies in the Philadelphia region in 2006 (ranked in the top 25) and 2007 (ranking TBA) in the Wharton Business School's "Philadelphia 100." The key to success for Frontage goes beyond our dedicated staff to our caring attitude in partnering with our clients. We have helped many companies produce the results that they need to continue their path to successful clinical trials and drug approvals.

Frontage has recently annoounced the equity investment (first step toward full acquisition) of Advanced Biomedical Research, an industry respected, full service Phase I - IV CRO. ABR operates a 72-bed, Phase I - II clinical center in Hackensack, equipped with the latest technologies, experienced clinical physicians, nurses, pharmacists and research personnel.

Frontage provides capabilities in the following areas:
• Bioanalytical services – Bioanalytical method development, validation and sample analysis supporting preclinical pharmacokinetic, toxicokinetic, and clinical pharmacokinetic studies, including biomarker testing;
• Pharmaceutical analysis – method development, validation and GMP sample testing for drug substances and finished products;
• Formulation development – immediate and sustained release tablets and capsules, injectables and oral liquids (including suspensions and emulsions), creams and ointments – product development, clinical supplies and commercialization services;
• Custom organic synthesis and API development, GMP manufacture and commercialization;
• Technology transfer of formulation and synthesis processes;
• Preclinical and biomarker research;
• Regulatory affairs and strategies;
• Data management and regulatory applications;
• Drug development and program management;
• GMP / GLP consulting services.

Ron Connolly’s Specialties:

Ron is involved in helping clients coordinate drug development activities and providing solutions to efficiently develop new drugs and generic formulations. Ron has over 18 years of drug development experience concentrated in scale up and commercialization of Active Pharmaceutical Ingredients and finished dosage forms. Ron also provides GMP and CMC consulting services to clients, utilizing his experience from more than 100 DMF/IND/NDA applications and 25+ FDA PAI and general GMP inspections.

Ron Connolly’s Experience

• Sr. Vice President

  Frontage Laboratories, Inc.

  (Privately Held; 51-200 employees; Pharmaceuticals industry)

  January 2003 — Present (5 years 10 months)

  Oversees the business development and customer relationships for US operations. Provides guidance to formulation development and organic synthesis staff to accomplish client and project goals. Develops strategies for business expansion and execution of existing business. Provides GMP consultation to clients and Quality Assurance functions. Implements new technologies to improve business operations.

• Technical Affairs Manager

  Flavine North America

  (Privately Held; 11-50 employees; Logistics and Supply Chain industry)

  November 1999 — December 2002 (3 years 2 months)

  Managed technical issues for all API's produced and sold on behalf of the company's clients. Prepared API manufacturing sites in Europe, China and India for FDA inspections and assisted in remediating outstanding manufacturing, quality and facilities issues. Provided consult and assistance to manufacturers and clients on DMF deficiency matters. Performed market research and developed new marketing strategies for the company.

• Sr. Research Scientist

  Wyeth Pharmaceuticals, esiLederle

  (Public Company; 5001-10,000 employees; WYE; Pharmaceuticals industry)

  September 1994 — November 1999 (5 years 3 months)

  Process Development Engineer and Project Manager for generic pharmaceutical development and commercial launch projects for esiLederle's Liquids and Parenterals group. Managed the technical and GMP issues for API's sourced by the division. Participated in GMP remediation projects and development of new quality systems for the manufacturing site. Participated in FDA inspections.

• Sr. Research Scientist

  Wyeth

  (Public Company; Pharmaceuticals industry)

  1994 — 1999 (5 years)

• Scientist

  Rhone Poulenc Rorer (Aventis)

  (Public Company; 1001-5000 employees; Pharmaceuticals industry)

  September 1991 — September 1994 (3 years 1 month)

  API development scientist / engineer. Participated in the scale up of API manufacturing processes (batch chemical processes) from the bench scale up to 300 gallon reactions. Performed IQ, OQ, PQ studies on process equipment and tuned PLC-controlled heat transfer equipment. Developed safe means of handling hazardous chemicals on the plant floor.

Ron Connolly’s Education

• Drexel University

  B.S., Chemical Engineering, 1986 — 1991

  Activities and Societies:

  Jazz performance scholarship

Additional Information

Ron Connolly’s Websites:

• My Company
• The River of Cherry Hill, NJ

Ron Connolly’s Interests:

Mentoring, Christianity, saxophone, music (writing, arranging), jazz, Celtic music and Irish history, Irish whistles and Uillean pipes, bible study, history, teaching, and training

Ron Connolly’s Groups:

ISPE, AAPS, The River Worship Center of Cherry Hill, NJ

•    BIO International Convention

Ron Connolly’s Honors:

Jazz performance scholarship - Drexel University

Ron Connolly’s Contact Settings

Interested In:

• new ventures
• job inquiries
• expertise requests
• business deals
• reference requests
• getting back in touch